Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs Solaya MD

Direct Meds
Graded #35

Higher grade

vs+13.3
Solaya MD
Graded #255

Lower grade

The verdict

Direct Meds takes it — 77.6/100 to 64.3/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDirect Meds +40
85
45
Dose & formulationDirect Meds +13
88
75
Clinical oversightSolaya MD +18
55
73
Labs & monitoringDirect Meds +26
78
52
FulfillmentSolaya MD +6
80
86
Contract termsDirect Meds +13
80
67
Direct Meds · left barSolaya MD · right bar

The numbers

MetricDirect MedsSolaya MD
WeighScore77.6/10064.3/100
GradeC+C
Scorecard rank#35#255
Semaglutide$249/mo sublingual · $297/mo injectableNot disclosed
Tirzepatide$299/mo sublingual · $399/mo injectableNot disclosed
CoverageNot publicly listedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Direct Meds

Graded #35 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed
Solaya MD

Graded #255 · C

Strengths

  • Names its dispensing pharmacy, VialsRX, with a street address and a phone number
  • Names a medical director with an NPI number and the medical practice behind him
  • Runs oral and injectable routes plus a microdose lane, and lists peptide products beside them
  • States service in all 50 U.S. states through affiliated providers and licensed pharmacies

Where it loses points

  • No drug-scoped price is published. The single visible figure, “pricing starts at $185”, names no molecule, no dose and no billing cycle
  • Every figure that does carry a cycle sits behind a create-account gate on a separate questionnaire domain
  • Two different medical directors are named for the same service — one on the About page, another in the FAQ and Terms
  • The medical group is spelled two different ways in two legal documents, as an LLC in one and a professional association in the other
  • Subscription payments are non-refundable, with no partial refunds
  • No compounding class is stated for VialsRX
  • Additional service fees appear in the terms of a testosterone program the site does not otherwise market

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard